Participated in arcoris bio's oversubscribed CHF 6.3M financing round for its biomedical diagnostics platform.
arcoris bio develops next-generation technologies for biomarker detection in research and diagnostics
arcoris bio develops next-generation technologies for biomarker detection in research and diagnostics. Its flagship MUSE® platform provides universal, programmable signal amplification to enable highly sensitive and multiplex assays that drive the future of digital pathology.